ArticleMikrochimica acta2025
Electrochemical immunosensor based on poly(5-aminoindole) for cancer biomarker pentraxin-3 detection.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pentraxin-3 (PTX-3) plays a critical role in regulating inflammation, immune response, angiogenesis, and tissue remodeling. As a serum biomarker, it holds a potential in cancer diagnostics and monitoring. Elevated expression of PTX-3 has been found in various cancers, namely lung, prostate, gastric, breast, and hepatic cancers. Here, a PTX-3 immunosensor was fabricated by utilizing poly(5-aminoindole) (P5AIn) to increase the current response and the electroactive surface area (ESA). (3-Aminopropyl)triethoxysilane (APTES) was used as a linker and as an electron transfer enhancer. The developed PTX-3 immunosensor (BSA/anti-PTX-3/APTES/P5AIn/SPCE) shows excellent performance for PTX-3 detection in a wide concentration range from 0.0001 to 2000 ng/mL with the LOD of 0.012 pg/mL. Furthermore, the sensor possessed good reproducibility (%RSD = 0.78), a long shelf-life of at least 4 weeks (% RSD = 0.89), and high specificity to PTX-3. The fabricated PTX-3 immunosensor was demonstrated in the measurement of PTX-3 concentrations in real blood serums from gastric patients. It has been shown as a potentially promising portable sensor for cancer diagnostics and monitoring for cancer patients in remote areas with a low cost.
Indexed as
Identifiers
40278909What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.